Intranasal clozapine sol-gel formulation induces long-term antipsychotic effects in experimental animals at a fraction of a comparable oral therapeutic dose
This study demonstrates that a poloxamer-based intranasal clozapine sol-gel formulation achieves long-term antipsychotic effects in rats at just 4% of the oral therapeutic dose while potentially mitigating gut microbiome disruption associated with oral administration.